The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | D | Dermatologicals | |
2 | D10 | Anti-acne preparations | |
3 | D10A | Anti-acne preparations for topical use | |
4 | D10AF | Antiinfectives for treatment of acne |
Code | Title | |
---|---|---|
D10AF01 | Clindamycin | |
D10AF02 | Erythromycin | |
D10AF03 | Chloramphenicol | |
D10AF04 | Meclocycline | |
D10AF05 | ||
D10AF06 | ||
D10AF07 | ||
D10AF51 | Clindamycin, combinations | |
D10AF52 | Erythromycin, combinations |
Active Ingredient | Description | |
---|---|---|
Chloramphenicol |
Chloramphenicol is a broad spectrum antibiotic which has activity against many types of Gram-positive and Gram-negative bacteria. It acts by interfering with bacterial protein synthesis. Chloramphenicol is widely distributed in body tissues and fluids and enters the cerebrospinal fluid. |
|
Clindamycin |
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
|
Erythromycin |
Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism. |
|
Minocycline |
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |
|
Nadifloxacin |
|
|
Sulfacetamide |
The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase. |
Title | Information Source | Document Type | |
---|---|---|---|
AKNEMYCIN PLUS Cutaneous solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CLINDAMYCIN Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CLINDAMYCIN Solution for Injection or Infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CLINDOXYL Gel | Health Products Regulatory Authority (ZA) | MPI, Generic | |
DALACIN C Capsule | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC | |
DALACIN CREAM Vaginal Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
DALACIN T Topical solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ZINDACLIN Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ZINERYT Powder and solvent for solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |